Jan 2011 to Present Vice President/Senior Quantitative Analyst and Market Neutral PMUniversity of Connecticut, SS&C Financial Accelerator
Aug 2009 to Jun 2010 Faculty Advisor/Lead ConsultantDeutsche Bank New York, NY Apr 2008 to Aug 2009 Associate/Proprietary Trader - Corporate and Investment BankingGoldman Sachs Asset Management New York, NY Mar 2006 to Mar 2008 Associate/Researcher - Quantitative Investment StrategiesUniversity of Washington, Center for Statistics and Social Sciences Washington, DC Mar 2001 to Oct 2001 Consultant for the statistical aspect of research designRobert McNeel & Associates Seattle, WA Jun 2000 to Sep 2000
Education:
University of Connecticut May 2011 Ph.D. in FinanceUniversity of Rochester, Simon Business School Jan 2003 to Jan 2006 MS/ABD in FinanceUniversity of Washington Jan 1999 to Jan 2002 MS in Mathematics/Statistics
Andrei V. Blokhin - Madison WI Benjamin Frydman - Madison WI Laurence J. Marton - Madison WI Karen M. Neder - Madison WI Jerry Shunneng Sun - Madison WI
Assignee:
SLIL Biomedical Corporation - Madison WI
International Classification:
C07B 4700
US Classification:
540145
Abstract:
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.
Andrei V. Blokhin - Madison WI Benjamin Frydman - Madison WI Laurence J. Marton - Madison WI Karen M. Neder - Madison WI Jerry Shunneng Sun - Madison WI
Assignee:
SLIL Biomedical, Corporation - Madison WI
International Classification:
C07K 200
US Classification:
530300, 549389, 549391, 549458, 549461, 552292
Abstract:
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.
Andrei V. Blokhin - Madison WI, US Benjamin Frydman - Madison WI, US Laurence J. Marton - Palo Alto CA, US Karen M. Neder - Madison WI, US Jerry Shunneng Sun - Madison WI, US
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.
Process For Selective Synthesis Of Enantiomers Of Substituted 1-(2-Amino-1-Phenyl-Ethyl)-Cyclohexanols
Paige Erin Mahaney - Pottstown PA, US Madelene Miyoko Antane - West Windsor NJ, US Jerry Shunneng Sun - Blauvelt NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
C07D 263/04
US Classification:
548230, 548215, 548225, 548229
Abstract:
A process for the enantioselective synthesis of an (S)- or (R)-1-[2-dimethylamino)-1-(methoxyphenyl)ethyl]cyclohexanol and analogues or salt thereof are described. The method involves the steps of (a) reacting an (S) or (R) 4-benzyloxazolidinone with a mixed anhydride of a methyoxyphenylacetic acid under conditions which form a oxazolidinone, (4S)- or (4R)-4-benzyl-3-[methyoxyphenyl]acetyl]-oxazolidin-2-one, (b) treating the (4S)- or (4R)-4-benzyl-3-[(methoxyphenyl)acetyl]-1,3-oxazolidin-2-one with an aprotic amine base and titanium chloride in a chlorinated solvent under conditions which permit formation of the corresponding anion, (c) mixing the corresponding anion with titanium chloride and cylcohexanone under conditions which permit an aldol reaction to form the corresponding (4S)- or (4R)-4-benzyl-3-[(2R)-2-(1-hydroxycyclohexyl)-2-(methoxyphenyl)acetyl]-1,3-oxazolidin-2-one,(d) hydrolyzing the (4S)— or (4R)-4-benzyl-3-[(2R)-2-(1-hydroxycyclohexyl)-2-(methoxyphenyl)acetyl]-1,3-oxazolidin-2-one to form a chiral acid (2S or 2R)-(1-hydroxycyclohexyl)-methoxyphenyl)acetic acid, (e) coupling the chiral phenylacid to a secondary amine to form an amide, and (f) reducing the amide to form an (S) or (R) 1[2-dimethylamino)-1-(methoxyphenyl)ethyl]cyclohexanol or a salt thereof.
Process For Preparing Quinoline Compounds And Products Obtained Therefrom
Christoph Dehnhardt - New York NY, US Sreenivasulu Megati - New City NY, US Jerry Sun - Blauvelt NY, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61P 25/00 A61K 31/551 C07D 243/00 C07D 471/06
US Classification:
514219, 540555
Abstract:
Methods for synthesizing tetrahydroquinoline-containing compounds are provided, along with synthetic intermediates and products associated with such methods.
Process For Preparing Quinoline Compounds And Products Obtained Therefrom
Christoph Dehnhardt - New York NY, US Sreenivasulu Megati - New City NY, US Jerry Sun - Blauvelt NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
C07D 471/04
US Classification:
428402, 540556
Abstract:
Methods for synthesizing tetrahydroquinoline-containing compounds are provided, along with synthetic intermediates and products associated with such methods.
Ortho-Quinone Derivatives, Novel Synthesis Therefor, And Their Use In The Inhibition Of Neoplastic Cell Growth
Benjamin J. Frydman - Madison WI Donald T. Witiak - late of Madison WI Jerry Shunneng Sun - Madison WI Andrew H. Geiser - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07D31192 C07D30791
US Classification:
549389
Abstract:
A process for the preparation of. beta. -lapachone and dunnione derivatives of formulae I and II ##STR1## wherein, the a solution of lawsone in dimethylsufoxide at a temperature of -78. degree. C. or less is reacted with lithium hydride forming the lithium salt of lawsone; alkylating the lithium salt with an allyl halide; and cyclizing the C-alkylated lawsone derivative.
Ortho-Quinone Derivatives Novel Synthesis Therefor And Their Use In The Inhibition Of Neoplastic Cell Growth
Benjamin J. Frydman - Madison WI Donald T. Witiak - Madison WI Jerry Shunneng Sun - Madison WI Andrew H. Geiser - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 3135 C07D31192
US Classification:
514454
Abstract:
The invention relates to. beta. -lapachone derivatives of formula II and compositions containing said compounds: ##STR1## wherein, R. sup. 5, R. sup. 6 and R. sup. 7 are as defined in the specification. The compounds are potent inhibitors of neoplastic cell growth and proliferation.
Flickr
Googleplus
Jerry Sun
Lived:
Columbus, OH
Work:
Honda R&D Americas, Inc. - Design Engineer (2011)
Education:
University of Miami - Aerospace Engineering
Tagline:
OG
Jerry Sun
Work:
Warner Bros. Entertainment - Supervisor (6) Panasonic Avionics Corporation - Program Planner (1-6)
Education:
UCLA Anderson - MBA, University of California, Berkeley - Economics & Statistics